Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pylori

References

• Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420–429. doi:10.1053/j.gastro.2017.04.02228456631
   PubMed Web of Science ®Google Scholar
• Zhou LY, Lin SR, Ding SG, et al. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. Chin Med J. 2014;127(8):1454–1458.24762588
   PubMed Web of Science ®Google Scholar
• Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112:212–238. doi:10.1038/ajg.2016.56328071659
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30. doi:10.1136/gutjnl-2016-312288.27707777
   PubMed Web of Science ®Google Scholar
• Fallone CA, Chiba N, van Zanten SV, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016;151(1):51–69.e14. doi:10.1053/j.gastro.2016.04.00627102658
   PubMed Web of Science ®Google Scholar
• Liu WZ, Xie Y, Lu H, et al. Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori and Peptic Ulcer. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.1247529512258
   PubMed Web of Science ®Google Scholar
• Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of Antibiotic Resistance in Helicobacter pylori: a Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018;155(5):1372–1382.e17. doi:10.1053/j.gastro.2018.07.00729990487
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-329276051
   PubMed Web of Science ®Google Scholar
• Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implication. Lancet Infect Dis. 2006;6(11):699–709. doi:10.1016/S1473-3099(06)70627-217067919
   PubMed Web of Science ®Google Scholar
• Tuan VP, Narith D, Tshibangu-Kabamba E, et al. A Next-Generation Sequencing-Based Approach to Identify Genetic Determinants of Antibiotic Resistance in Cambodian Helicobacter pylori Clinical Isolates. J Clin Med. 2019;8:858. doi:10.3390/jcm8060858
   Web of Science ®Google Scholar
• Lauener FN, Imkamp F, Lehours P, et al. Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori. J Clin Med. 2019;8(1):53.  doi:10.3390/jcm8010053.
   Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and Grading of Gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis. Houston. 1996;20(10):1161–1181. doi:10.1097/00000478-199610000-00001
   Web of Science ®Google Scholar
• Wang YH, Wang FF, Gong XL, et al. Genotype profiles of Helicobacter pylori from  gastric biopsies and strains with antimicrobial-induced resistance. Therap Adv Gastroenterol. 2020;13:1756284820952596. doi:10.1177/1756284820952596 .
   Google Scholar
• Seo SI, Do BJ, Kang JG, et al. Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance. J Clin Med. 2019;9(1):54. doi:10.3390/jcm9010054
   Web of Science ®Google Scholar
• Van den Poel B, Gils S, Micalessi I. et al. Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay. Acta Clin Belg;2019. 1–7. doi:10.1080/17843286.2019.1685741
   Web of Science ®Google Scholar
• Arenas A, Serrano C, Quiñones L, et al. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis. Sci Rep. 2019;9(1):20070. doi:10.1038/s41598-019-56399-731882676
   PubMed Web of Science ®Google Scholar
• Arslan N, Yılmaz O, Demiray-Gürbüz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol. 2017;23(16):2854–2869. doi:10.3748/wjg.v23.i16.285428522904
   PubMed Web of Science ®Google Scholar
• van Doorn LJ, Glupczynski Y, Kusters JG, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother. 2001;45(5):1500–1504. doi:10.1128/AAC.45.5.1500-1504.200111302817
   PubMed Web of Science ®Google Scholar
• Shetty V, Lamichhane B, Tay CY, et al. High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients. Gut Pathog. 2019;11(1):21. doi:10.1186/s13099-019-0305-x31110563
   PubMed Web of Science ®Google Scholar
• Salehi N, Attaran B, Eskini N, et al. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: a molecular docking study of prevalent GyrA mutations. Helicobacter. 2019;24(5):e12628. doi:10.1111/hel.1262831282059
   PubMed Web of Science ®Google Scholar
• Kageyama C, Sato M, Sakae H, et al. Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan. Infect Drug Resist. 2019;12:597–602. doi:10.2147/IDR.S19645230881065
   PubMed Web of Science ®Google Scholar
• Zhang XY, Shen WX, Chen CF, et al. Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR. Cancer Med. 2019;8(4):1633–1640. doi:10.1002/cam4.198630864275
   PubMed Web of Science ®Google Scholar
• Gao C, Du SY, Fang L, Fan YH, Song AP, Chen H. Eradication Treatment of Helicobacter pylori Infection Based on Molecular Pathologic Antibiotic Resistance. Infect Drug Resist. 2020;13:69–79. doi:10.2147/IDR.S23216932021321
   PubMed Web of Science ®Google Scholar
• Graham DY, Dore MP, Lu H. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. Expert Rev Anti Infect Ther. 2018;16(9):679–687. doi:10.1080/14787210.2018.151142730102559
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Q, Liang X, et al. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015;64(11):1715–1720. doi:10.1136/gutjnl-2015-30990026338726
   PubMed Web of Science ®Google Scholar
• McNicholl AG, Bordin DS, Lucendo A, et al. Combination of bismuth and standard triple therapy eradicates helicobacter pylori infection in more than 90% of patients. Clin Gastroenterol Hepatol. 2020;18(1):89–98. doi:10.1016/j.cgh.2019.03.04830978536
   PubMed Web of Science ®Google Scholar
• Gisbert JP, McNicholl AG. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter. 2017;22(4):e12392. doi:10.1111/hel.12392
   Web of Science ®Google Scholar
• Chen MJ, Chen CC, Chen YN, et al. Systematic Review with Meta-Analysis: concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection[J]. Am J Gastroenterol. 2018;113(10):1444–1457. doi:10.1038/s41395-018-0217-230171216
   PubMed Web of Science ®Google Scholar
• Boyanova L, Ilieva J, Gergova G, et al. Numerous risk factors for Helicobacter  pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. J Med Microbiol. 2012;61:85–93. doi:10.1099/jmm.0.035568-021873378
   PubMed Web of Science ®Google Scholar
• Bayati S, Alebouyeh M, Amirmozafari N, Ebrahimi Daryani N, Talebi M, Zali MR. Histological changes in refractory Helicobacter pylori infection and its relationship with increased levels of resistance to antibiotics and therapeutic regimens: one-year follow-up. APMIS. 2020;128(1):25–34. doi:10.1111/apm.1300131628820
   PubMed Web of Science ®Google Scholar
• Li L, Ke Y, Yu C, et al. Antibiotic resistance of Helicobacter pylori in Chinese children: a multicenter retrospective study over 7 years. Helicobacter. 2017;22(3):e12373. doi:10.1111/hel.12373
   Web of Science ®Google Scholar